ICON
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ICON
Jul 22, 2024, 22:39 |
Blog
Muaiad Kittaneh: A special invitation to join ASCO Direct in Michigan
Muaiad Kittaneh, Senior Director at ICON, shared a post on LinkedIn: ''As the program chair,…
May 12, 2024, 07:27 |
Drugs
Tanja Obradovic summarizes the latest news on immunotherapy with chemoradiation NSCLC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: “Based on what…
May 1, 2024, 10:55 |
Blog
Tanja Obradovic: The spotlight of FDA last week
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on LinkedIn:…
May 1, 2024, 09:57 |
Drugs
Tanja Obradovic: Dostarlimab chemotherapy in primary advanced or recurrent endometrial cancer
Tanja Obradovic, Vice President, Oncology Scientific Affairs at ICON, shared on LinkedIn: "Further inroads of…
Apr 28, 2024, 18:45 |
Blog
Tanja Obradovic: Absolutely great meeting and productive exchange around trends and needs in today's pharma world
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared a post by Why Summits…
Apr 12, 2024, 17:18 |
Drugs
Tanja Obradovic: Interesting statistics on the nature of licensing deals in pharmaceutics during last year
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Interesting…
Apr 12, 2024, 16:43 |
Drugs
Tanja Obradovic: Exciting new vaccine is about to start Phase III in advanced NSCLC patients that progressed following immunotherapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Exciting…
Apr 12, 2024, 05:16 |
Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Feb 17, 2024, 16:27 |
Drugs
Tanja Obradovic: BioXcel Therapeutics received Fast Track designation by the FDA for BXCL701
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "Biotech companies…
Sep 1, 2023, 22:27 |
Blog
Paul Fenton: Our Icon Cancer Centre - Australia and New Zealand teams across the country love getting behind Daffodil Day to raise funds and awareness for the Cancer Council.
All:
10
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube